US Patent 10668036 Deuterated analogs of D-serine and uses thereof
Patent 10668036 was granted and assigned to Concert Pharmaceuticals on June, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
106680360
Date of Patent
June 2, 2020
0Patent Application Number
164599160
Date Filed
July 2, 2019
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
106680360
Date of Patent
June 2, 2020
0Patent Application Number
164599160
Date Filed
July 2, 2019
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10668036 Deuterated analogs of D-serine and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10668036
Date of patent
June 2, 2020
Patent application number
16459916
Date Filed
July 2, 2019
Patent primary examiner
Find more entities like US Patent 10668036 Deuterated analogs of D-serine and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
